Heterogeneity of MprF Sequences in Methicillin-resistant Staphylococcus Aureus Clinical Isolates: Role in Cross-resistance Between Daptomycin and Host Defense Antimicrobial Peptides
Overview
Authors
Affiliations
Over the past several years, single-nucleotide polymorphisms (SNPs) within the mprF open reading frame (ORF) have been proposed to be associated with a gain-of-function phenotype in terms of daptomycin (DAP) nonsusceptibility (referred to as daptomycin resistance [DAP-R] herein for ease of presentation) in Staphylococcus aureus. We investigated the frequencies of SNPs within the mprF ORF and the relationships of such SNPs to cross-resistance between DAP and cationic host defense peptides (HDPs). Thirty-five well-characterized, unique DAP-susceptible (DAP-S) and DAP-R methicillin-resistant S. aureus (MRSA) isolates of the clonal complex 5 genotype were used. In addition to mprF SNPs and DAP-HDP cross-resistance, several other key genotypic and phenotypic metrics often associated with DAP-R were delineated, as follows: (i) mprF expression, (ii) membrane phospholipid content, (iii) positive surface charge, (iv) DAP binding, and (v) cell wall thickness profiles. A number of DAP-S strains (MICs of ≤ 1 μg/ml) exhibited mprF SNPs, occasionally with high-level mprF sequence variation from the genotype reference strain. However, none of these SNPs were localized to well-chronicled mprF hot spot locations associated with DAP-R in S. aureus. In contrast, all 8 DAP-R isolates demonstrated SNPs within such known mprF hot spots. Moreover, only the DAP-R strains showed MprF gain-of-function phenotypes, enhanced mprF expression, higher survival against two prototypical HDPs, and reduced DAP binding. Although a heterogenous array of mprF SNPs were often found in DAP-S strains, only selected hot spot SNPs, combined with concurrent mprF dysregulation, were associated with the DAP-R phenotype.
Xu Y, Xiao Y, Zhao H, Wang B, Yu J, Shang Y Front Cell Infect Microbiol. 2024; 14:1453233.
PMID: 39512591 PMC: 11540788. DOI: 10.3389/fcimb.2024.1453233.
Freeman C, Hansen T, Urbauer R, Wilkinson B, Singh V, Hines K mSphere. 2024; 9(6):e0011524.
PMID: 38752757 PMC: 11332330. DOI: 10.1128/msphere.00115-24.
Genomic Insights into Isolates Exhibiting Diminished Daptomycin Susceptibility.
Gomez-Casanova N, Gutierrez-Zufiaurre M, Blazquez de Castro A, Munoz-Bellido J Pathogens. 2024; 13(3).
PMID: 38535549 PMC: 10974884. DOI: 10.3390/pathogens13030206.
Xu L, Henriksen C, Mebus V, Guerillot R, Petersen A, Jacques N Antimicrob Agents Chemother. 2023; 67(6):e0032823.
PMID: 37184389 PMC: 10269151. DOI: 10.1128/aac.00328-23.
Freeman C, Hansen T, Urbauer R, Wilkinson B, Singh V, Hines K bioRxiv. 2023; .
PMID: 37090586 PMC: 10120677. DOI: 10.1101/2023.04.11.536441.